GlucoTrack (NASDAQ:GCTK) Trading 2.9% Higher

Shares of GlucoTrack, Inc. (NASDAQ:GCTK) shot up 2.9% during trading on Wednesday . The stock traded as high as $1.73 and last traded at $1.73. 2,524 shares changed hands during mid-day trading, a decline of 92% from the average session volume of 31,967 shares. The stock had previously closed at $1.68.

GlucoTrack Price Performance

The stock has a market cap of $9.48 million, a price-to-earnings ratio of -0.84 and a beta of 0.06. The stock’s 50 day moving average price is $2.40 and its two-hundred day moving average price is $1.86. The company has a quick ratio of 1.31, a current ratio of 1.31 and a debt-to-equity ratio of 0.52.

GlucoTrack (NASDAQ:GCTK) last issued its quarterly earnings data on Wednesday, May 15th. The company reported ($0.60) earnings per share (EPS) for the quarter.

Insiders Place Their Bets

In other news, Director Drew Sycoff bought 36,508 shares of the business’s stock in a transaction dated Monday, April 22nd. The stock was purchased at an average cost of $6.30 per share, with a total value of $230,000.40. Following the acquisition, the director now directly owns 590,251 shares in the company, valued at $3,718,581.30. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 17.70% of the company’s stock.

About GlucoTrack

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain.